Segment Information (Tables)

3 Months Ended

Mar. 31, 2020

Segment Information

Summary of results of operations by segment

			Contract		Corporate		Total
Three Months Ended March 31, 2020	Therapeutics		Research		and Other		Company
Total revenue	$	218	$	3,407	$	(2,218)	$	1,407
Cost of revenue		—		3,386		(2,117)		1,269
Research and development		9,545		—		(101)		9,444
General and administrative		—		753		5,447		6,200
Loss from operations	$	(9,327)	$	(732)	$	(5,447)	$	(15,506)
Loss from discontinued operations	$	(257)	$	—	$	(1)	$	(258)
			Contract		Corporate		Total
Three Months Ended March 31, 2019	Therapeutics		Research		and Other		Company
Total revenue	$	—	$	5,190	$	(3,927)	$	1,263
Cost of revenue		—		5,037		(3,830)		1,207
Research and development		19,740		—		(97)		19,643
General and administrative		—		531		6,933		7,464
Loss from operations	$	(19,740)	$	(378)	$	(6,933)	$	(27,051)
Loss from discontinued operations	$	(9,415)	$	—	$	(869)	$	(10,284)